نتایج جستجو برای: second malignancy
تعداد نتایج: 654456 فیلتر نتایج به سال:
Although treatment of pediatric Hodgkin disease has become highly effective over the past 40 years, a number of patients have developed concerning late effects, such as secondary malignancies. These cancers may occur years to decades after remission and arise in the breast, thyroid, gastrointestinal tract, lung, skin, urogenital tract, and brain. There is also an increased risk of leukemia and ...
BACKGROUND Heightened risks of second cancers have been reported in patients with nonmelanoma cancer of the skin (NMSC), but this association has not been studied in a large, ethnically diverse, multigeographic population. METHODS This cross-sectional study assessed the association of NMSC with another malignancy in the Women's Health Initiative Observational Study, a study that was conducted...
Background and Objectives: Radiotherapy (RT) plays an important role in the treatment for locally advanced rectal cancer patients. It can bring radio exposure together with survival benefit. Cancer survivors are generally at increased risk second malignancies, receiving RT may have higher risks than not RT. Whether of all-site malignancy increase after is still debated. This study aims to compa...
Hodgkin’s disease is one of the most common childhood malignancies that with correct diagnosis and effective treatment is curable and without treatment is leading to death. The survival of patients with Hodgkin’s disease has dramatically improved over the past 30 years because of advances in treatment. However, concern for the risk of long tern complications has resulted in a number of tria...
The Clinical and Translational Science Award (CTSA) Consortium Workshop was conceived as a venue to foster communication among academic medical centers (AMCs) in the development of methods to improve clinical research management. The consortium, comprised of 46 awardee sites as of 2009, many with multiple AMCs, is expected to expand to 60 sites when fully implemented. At the 2nd Annual CTSA Cli...
We report a young male patient who developed plasma cell myeloma/plasmacytoma 11 years after having received an allogeneic hematopoietic cell transplantation for AML. The patient received a second transplantation from the same donor without immunosuppression and developed graft-versus-host disease (GVHD). Our observation has two aspects that warrant attention: first, insufficiency of long-term ...
Destructive bone lesions occurring in patients who have previously had a malignancy are generally assumed to be a metastasis from that malignancy. We reviewed 60 patients with a previous history of malignancy, who presented with a solitary bone lesion that was subsequently found to be a new and different primary sarcoma of bone. These second malignancies occurred in three distinct groups of pat...
OBJECTIVE We noticed that a significant proportion of our patients with head and neck mucoepidermoid carcinoma (HNMEC) had second primary malignancies. To our knowledge, such an association has never been described. The aim of our study is to elucidate the association between second primary malignancies and HNMEC. STUDY DESIGN Case series with chart review. SETTING Tertiary referral center....
ewing’s sarcoma is a round cell malignancy of bone and soft tissue that occurs predominately in adolescents and young adults.it is an uncommon malignancy, but is recognized as the second most prevalent primary bone tumor worldwide. extraosseous ewing’s sarcoma is extremely rare and can affect the skin, soft tissues, or viscera. prognostic and therapeutic features of ewing’s extraosseous tumors ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید